Vardenafil Hydrochloride Tablet
Product Images NDC 42291-847

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 42291-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

847 30 10mg

Packaging label for Vardenafil Hydrochloride Tablets 10 mg by AvKARE. The label indicates 30 tablets in the package, Rx only. It features dosage information, storage recommendations, manufacturer details, and a barcode. The label emphasizes the active ingredient with the strength of 10 mg per tablet.*

FDA Label Image

848 30 20mg

Label for Vardenafil Hydrochloride Tablets 20 mg, oral tablets, manufactured by AvKARE. The label indicates the product contains 30 tablets, is prescription only, and includes an NDC number 42291-848-30. Storage instructions specify controlled room temperature between 15-30°C.*

FDA Label Image

Chemical Structure (Vardenafil Figure 1)

Chemical structure of Vardenafil Hydrochloride depicted with a detailed molecular arrangement, including the hydrochloride and hydrate components as indicated.*

FDA Label Image

Figure 1 (Vardenafil Figure 2)

A set of three line graphs showing mean maximal changes in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) related to the timing of Vardenafil treatment before NTG. Each graph plots measurements at 24h, 8h, 4h, and 1h intervals prior to NTG administration.*

FDA Label Image

Figure 2 (Vardenafil Figure 3)

A line graph depicting the mean change in mmHg over time (hours) comparing placebo and Vardenafil 5 mg under two conditions: simultaneous administration and 6-hour separation. The graph has a y-axis labeled 'Mean Change (mmHg)' ranging from -15 to 15 and an x-axis labeled 'Time (Hr)' spanning 0 to 6 hours, with distinct markers for each treatment and condition.*

FDA Label Image

Figure 3 (Vardenafil Figure 4)

A line graph depicting mean change in mmHg over 6 hours. The plot compares placebo and Vardenafil 5 mg under simultaneous and 8-hour separation conditions, showing trends in mean change values for each group across time.*

FDA Label Image

Figure 4 (Vardenafil Figure 5)

A line chart showing mean change in mmHg over time in hours for Vardenafil Hydrochloride tablets at 10 mg and 20 mg doses compared to placebo during two stages. The graph includes four lines representing placebo (Stage 1 and Stage 2) and Vardenafil (10 mg and 20 mg), with mean change measured on the y-axis and time on the x-axis.*

FDA Label Image

Figure 5 (Vardenafil Figure 6)

Line graph depicting the mean change in mmHg over time (0 to 6 hours) for Vardenafil at 5 mg and 10 mg doses compared with placebo during two stages. The graph shows trends in blood pressure change, with Vardenafil doses generally causing reductions compared to placebo.*

FDA Label Image

Figure 6 (Vardenafil Figure 7)

Line graph titled 'TERAZOSIN' showing mean change in mmHg over time (hours) for placebo, 10 mg, and 20 mg Vardenafil under two conditions: 6-hour separation and simultaneous administration. The graph depicts blood pressure changes for each treatment group from 0 to 6 hours, with distinct markers for each group.*

FDA Label Image

Figure 7 (Vardenafil Figure 8)

Line graph titled 'Tamsulosin' showing mean change in mmHg over 6 hours. It compares placebo and Vardenafil 10 mg and 20 mg administered either with 6-hour separation or simultaneously, illustrating blood pressure changes with different timing conditions.*

FDA Label Image

Figure 8 (Vardenafil Figure 9)

A line graph depicting plasma concentration (µg/L) versus time (hours). The graph shows plasma concentration rising sharply to a peak near 1 hour followed by a gradual decline over 24 hours with error bars indicating variability in the measurements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.